BARCLAYS PLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 188 filers reported holding BEAM THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$2,947
-50.6%
125,827
-30.4%
0.00%
-66.7%
Q1 2024$5,970
-11.7%
180,676
-27.3%
0.00%
+50.0%
Q4 2023$6,761
+42.3%
248,384
+25.7%
0.00%
-33.3%
Q3 2023$4,752
+2.9%
197,647
+36.7%
0.00%0.0%
Q2 2023$4,617
+30.4%
144,532
+25.0%
0.00%
+50.0%
Q1 2023$3,542
-25.5%
115,629
-4.9%
0.00%0.0%
Q4 2022$4,757
-99.9%
121,619
+11.8%
0.00%
-66.7%
Q3 2022$5,179,000
+339.3%
108,736
+256.9%
0.01%
+500.0%
Q2 2022$1,179,000
+37.3%
30,469
+102.8%
0.00%0.0%
Q1 2022$859,00015,0250.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,346,934$74,937,60345.33%
HSG Holding Ltd 796,089$25,419,1222.91%
Deep Track Capital, LP 1,317,316$42,061,9001.95%
Redmile Group, LLC 1,485,199$47,422,4041.82%
ARK Investment Management 8,382,595$267,656,2461.77%
Casdin Capital, LLC 570,000$18,200,1001.59%
Yiheng Capital Management, L.P. 463,800$14,809,1340.80%
Temasek Holdings (Private) Ltd 4,317,789$137,867,0030.80%
Alphabet Inc. 321,604$10,268,8150.55%
FARALLON CAPITAL MANAGEMENT LLC 3,441,522$109,887,7970.55%
View complete list of BEAM THERAPEUTICS INC shareholders